BY002: Clinical Trials

2 trials of BY002, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Recruiting 2

Follow BY002: new trials by email Literature Review of BY002 trials Research Report on BY002

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Healthy Participants Randomized, Double-blind, Placebo-controlled, Phase Ⅰ
BY002, Placebo - Healthy Participants Study
Phase 1RecruitingFirst Affiliated Hospital of Zhejiang University1042026-06-012026-06-10
BY002 IIT Study in R/R Acute Leukemia
BY002 - Acute Leukemia, KMT2A Rearrangements or NPM1 Mutations Acute Leukemia
Phase 1RecruitingThe First Affiliated Hospital of Soochow University182026-03-152026-03-18

Conditions studied

Recurrence (1)

Sponsors

First Affiliated Hospital of Zhejiang University (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

China (2)

Top investigators

Suning Chen, MD, PhD (1)